Skip to content

Collegium Pharmaceutical, Inc. COLL Amortization of capitalized software and acquired intangible assets

Amortization of capitalized software and acquired intangible assets at other companies

Catalyst Pharmaceutical logo
Catalyst PharmaceuticalCPRX
Acadia Pharmaceuticals logo
Acadia PharmaceuticalsACAD
Axsome Therapeutics logo
Axsome TherapeuticsAXSM

Other financials

Income statement

See full
Revenue$193.5M+8.9%
Gross profit$117.2M+20.5%
Operating income$30.9M+42.5%
Net income$14.5M+500%
EPS (diluted)$0.40+471%

Balance sheet

See full
Cash & equivalents$289.6M+147%
Total debt$5.2M-19.5%
Total equity$312.4M+33.3%
Total assets$1.7B+1.3%

Cash flow

See full
Operating cash flow$57.1M+3.1%
CapEx$270.0K-66.2%
Free cash flow$56.8M+4.1%

Valuation

See full
Market cap$1.15B+17.9%
Enterprise value$869.67M-0.3%
P/E15.4×-6.9×
P/S1.5×0.0×

Profitability

See full
Gross margin60.7%+3.0pp
Operating margin23.7%+2.3pp
Net margin9.4%+2.8pp
FCF margin41.4%+10.4pp

Returns & leverage

See full
Return on equity27.4%+8.2pp
Debt / equity0.0×
Current ratio1.7×+0.6×

Where this comes from

Reported directly by Collegium Pharmaceutical, Inc. in its filing.

Tagged under the XBRL concept us-gaap:AmortizationOfIntangibleAssets.

The official record: Collegium Pharmaceutical, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Collegium Pharmaceutical, Inc.'s amortization of capitalized software and acquired intangible assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Collegium Pharmaceutical, Inc.'s amortization of capitalized software and acquired intangible assets?
Collegium Pharmaceutical, Inc. (COLL) reported amortization of capitalized software and acquired intangible assets of $55.47M in Q1 2026.
How has Collegium Pharmaceutical, Inc.'s amortization of capitalized software and acquired intangible assets changed year-over-year?
Collegium Pharmaceutical, Inc.'s amortization of capitalized software and acquired intangible assets decreased by 0.0% year-over-year, from $55.47M to $55.47M.
What is the long-term trend for Collegium Pharmaceutical, Inc.'s amortization of capitalized software and acquired intangible assets?
Over 2 years (2021 to 2024), Collegium Pharmaceutical, Inc.'s amortization of capitalized software and acquired intangible assets has grown at a 56.9% compound annual growth rate (CAGR), from $67.18M to $165.3M.